BioMed Laboratory
 School of Life Sciences
 Nanjing University

Lab-Intro > Publications > Year 2014
Year 2014
  •   Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy. Zhan, X., L. Jia, Y. Niu, H. Qi, X. Chen, Q. Zhang, J. Zhang, Y. Wang, L. Dong and C. Wang. Biomaterials. 2014;35(38):10046-10057.
  •   Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy. Zhan, X., L. Jia, Y. Niu, H. Qi, X. Chen, Q. Zhang, J. Zhang, Y. Wang, L. Dong and C. Wang. Biomaterials. 2014;35(38):10046-10057.
  •   Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy. Zhan, X., L. Jia, Y. Niu, H. Qi, X. Chen, Q. Zhang, J. Zhang, Y. Wang, L. Dong and C. Wang. Biomaterials. 2014;35(38):10046-10057.
  •   A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy. Zhu, Q., L. Jia, Z. Gao, C. Wang, H. Jiang, J. Zhang and L. Dong. Mol Pharm. 2014;11(10):3269-3278.
  •   Lower Irisin Level in Patients with Type 2 Diabetes Mellitus: a Case-control Study and Meta-analysis. Zhang, C., Z. Ding, G. Lv, J. Li, P. Zhou and J. Zhang. J Diabetes. 2014.
  •   Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth. Yin, Y., X. Cai, X. Chen, H. Liang, Y. Zhang, J. Li, Z. Wang, X. Chen, W. Zhang, S. Yokoyama, C. Wang, L. Li, L. Li, D. Hou, L. Dong, T. Xu, T. Hiroi, F. Yang, H. Ji, J. Zhang, K. Zen and C. Y. Z
  •   MicroRNA-101 suppresses liver fibrosis by targeting the TGFbeta signalling pathway. Tu, X., H. Zhang, J. Zhang, S. Zhao, X. Zheng, Z. Zhang, J. Zhu, J. Chen, L. Dong, Y. Zang and J. Zhang. J Pathol. 2014;234(1):46-59.
  •   A 3-D artificial colon tissue mimic for the evaluation of nanoparticle-based drug delivery system. Huang, Z., Z. Wang, S. Long, H. Jiang, J. Chen, J. Zhang and L. Dong. Mol Pharm. 2014;11(7):2051-2061.
  •   miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC. Wang, N., H. Liang, Y. Zhou, C. Wang, S. Zhang, Y. Pan, Y. Wang, X. Yan, J. Zhang, C. Y. Zhang, K. Zen, D. Li and X. Chen. PLoS One. 2014;9(8):e105570.
  •   miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12beta during murine colitis and human Crohn\'s disease. Huang, Z., T. Shi, Q. Zhou, S. Shi, R. Zhao, H. Shi, L. Dong, C. Zhang, K. Zeng, J. Chen and J. Zhang. Gut. 2014;63(8):1247-1257.
  •   3,3\'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. Zhang, Z., Z. Gao, W. Hu, S. Yin, C. Wang, Y. Zang, J. Chen, J. Zhang and L. Dong. Br J Pharmacol. 2013;170(3):649-660.
  •   Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy. Zhan, X., L. Jia, Y. Niu, H. Qi, X. Chen, Q. Zhang, J. Zhang, Y. Wang, L. Dong and C. Wang. Biomaterials. 2014;35(38):10046-10057.
  •   A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy. Zhu, Q., L. Jia, Z. Gao, C. Wang, H. Jiang, J. Zhang and L. Dong. Mol Pharm. 2014;11(10):3269-3278.
  •   Lower Irisin Level in Patients with Type 2 Diabetes Mellitus: a Case-control Study and Meta-analysis. Zhang, C., Z. Ding, G. Lv, J. Li, P. Zhou and J. Zhang. J Diabetes. 2014.
  •   Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth. Yin, Y., X. Cai, X. Chen, H. Liang, Y. Zhang, J. Li, Z. Wang, X. Chen, W. Zhang, S. Yokoyama, C. Wang, L. Li, L. Li, D. Hou, L. Dong, T. Xu, T. Hiroi, F. Yang, H. Ji, J. Zhang, K. Zen and C. Y. Z
  •   MicroRNA-101 suppresses liver fibrosis by targeting the TGFbeta signalling pathway. Tu, X., H. Zhang, J. Zhang, S. Zhao, X. Zheng, Z. Zhang, J. Zhu, J. Chen, L. Dong, Y. Zang and J. Zhang. J Pathol. 2014;234(1):46-59.
  •   A 3-D artificial colon tissue mimic for the evaluation of nanoparticle-based drug delivery system. Huang, Z., Z. Wang, S. Long, H. Jiang, J. Chen, J. Zhang and L. Dong. Mol Pharm. 2014;11(7):2051-2061.
  •   miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC. Wang, N., H. Liang, Y. Zhou, C. Wang, S. Zhang, Y. Pan, Y. Wang, X. Yan, J. Zhang, C. Y. Zhang, K. Zen, D. Li and X. Chen. PLoS One. 2014;9(8):e105570.
  •   miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12beta during murine colitis and human Crohn\'s disease. Huang, Z., T. Shi, Q. Zhou, S. Shi, R. Zhao, H. Shi, L. Dong, C. Zhang, K. Zeng, J. Chen and J. Zhang. Gut. 2014;63(8):1247-1257.
  •   3,3\'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. Zhang, Z., Z. Gao, W. Hu, S. Yin, C. Wang, Y. Zang, J. Chen, J. Zhang and L. Dong. Br J Pharmacol. 2013;170(3):649-660.